Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cellsJ E Nutt, J Lunec
British Journal of Cancer|October 1, 1991
Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cellsJ E Nutt, A L Harris, J Lunec
British Journal of Cancer|July 31, 1998
Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumoursJ E Nutt, J K Mellon, K Qureshi, et al.
British Journal of Cancer|April 15, 2004
Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2J E Nutt, H P Lazarowicz, J K Mellon, et al.
British Journal of Cancer|February 22, 2007
hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumoursJ E Nutt, P A Foster, J K Mellon, et al.
BJU International|March 5, 2003
Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urineJ E Nutt, G C Durkan, J K Mellon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladderG C Durkan, J E Nutt, P H Rajjayabun, et al.
British Journal of Cancer|January 7, 2010
The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapyJ E Nutt, A R A Razak, K O'Toole, et al.
Pageof 1